LU, CHUNG KUNG,卢重光,盧重光,LIOU, KUO TONG,刘国同,劉國同,TSAI, KENG CHANG,蔡耿彰,蔡耿彰,LIU, HUI KANG,刘慧康,劉慧康,LIN, YUN LIAN,林云莲,林雲蓮,SHEN, YUH CHIANG,沈郁强,沈郁強
申请号：
TW108116458
公开号：
TW202002962A
申请日:
2019.05.13
申请国别(地区):
TW
年份:
2020
代理人:
摘要：
The present invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof for the treatment or prevention of neurological diseases, such as stroke, brain trauma, neurodegenerative diseases, amyotrophic lateral sclerosis, depression, causes Stroke-induced motor dysfunction and optic nerve damage.本發明涉及一種式(I)化合物或其醫藥上可接受之鹽類在治療或預防神經性疾病之用途，例如中風、腦創傷、神經退化性疾病、肌萎縮性側索硬化、憂鬱症、因中風引發之運動功能障礙及視神經損傷等疾病。
